In mammals, the Y chromosome is a dominant male determinant, causing the
bipotential gonad to develop as a testis. Recently, cases of familial and
spontaneous 46,XY disorders of sex development (DSD) have been attributed to
mutations in the human gene encoding mitogen-activated protein kinase kinase
kinase 1, MAP3K1, a component of the mitogen-activated protein kinase (MAPK)
signal transduction pathway. In individuals harbouring heterozygous mutations in
MAP3K1, dysregulation of MAPK signalling was observed in
lymphoblastoid cell lines, suggesting a causal role for these mutations in
disrupting XY sexual development. Mice lacking the cognate gene,
Map3k1, are viable and exhibit the eyes open at birth (EOB)
phenotype on a mixed genetic background, but on the C57BL/6J genetic background
most mice die at around 14.5 dpc due to a failure of erythropoiesis in the fetal
liver. However, no systematic examination of sexual development in
Map3k1-deficient mice has been described, an omission that
is especially relevant in the case of C57BL/6J, a genetic background that is
sensitized to disruptions to testis determination. Here, we report that on a
mixed genetic background mice lacking Map3k1 are fertile and
exhibit no overt abnormalities of testis development. On C57BL/6J, significant
non-viability is observed with very few animals surviving to adulthood. However,
an examination of development in Map3k1-deficient XY embryos on
this genetic background revealed no significant defects in testis determination,
although minor abnormalities were observed, including an increase in gonadal
length. Based on these observations, we conclude that MAP3K1 is not required for
mouse testis determination. We discuss the significance of these data for the
functional interpretation of sex-reversing MAP3K1 mutations in
humans.